Esperion Therapeutics, Inc.
Board Member
2020-05-28–present
Board Member
Esperion Therapeutics, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Tim M. Mayleben is recorded as Board Member at Esperion Therapeutics, Inc.. The proxy statement of Esperion Therapeutics, Inc. reports total compensation of $8,227,286 for Tim M. Mayleben in fiscal 2021, including a base salary of $265,152. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Esperion Therapeutics, Inc.
Board Member
SEC 8-K
2020-05-28–present
Esperion Therapeutics, Inc.
CEO
Proxy statement
Start not stated–2021-04-15
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
Esperion Therapeutics, Inc.
Board Member
2020-05-28–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Esperion Therapeutics, Inc. | Former Chief Executive Officer | $265,152 | $8,227,286 |
| 2020 | Esperion Therapeutics, Inc. | Former Chief Executive Officer | $700,000 | $6,925,024 |
| 2019 | Esperion Therapeutics, Inc. | Former Chief Executive Officer | $625,000 | $1,080,850 |
| 2018 | Esperion Therapeutics, Inc. | President and Chief Executive Officer | $600,000 | $9,724,839 |
| 2017 | Esperion Therapeutics, Inc. | President and Chief Executive Officer | $557,500 | $5,013,460 |
No call appearances or filed executive changes recorded yet.